Lacutamab in patients with relapsed and/or refractory mycosis fungoides: Results from the TELLOMAK phase 2 trial.

被引：0
|
作者：
Porcu, Pierluigi
Bagot, Martine
Ram-Wolff, Caroline
Kim, Youn H.
Huen, Auris
Dalle, Stephane
Poligone, Brian
Mehta-Shah, Neha
Modeste, Anne Benedicte Duval
Zinzani, Pier Luigi
Woei-A-Jin, Feng Jung Sherida Harriette
Eigentler, Thomas
Combalia, Andrea
Sokol, Lubomir
Battistella, Maxime
Gru, Alejandro
Teisserenc, Helene Moins
Viotti, Julien
Paiva, Christine
Chammard, Agnes Boyer
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA
[2] Univ Paris Cite, Hop St Louis, INSERM, U976, Paris, France
[3] Stanford Univ, Dept Dermatol, Multidisciplinary Cutaneous Lymphoma Program, Stanford, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX USA
[5] Hosp Civils Lyon, Dept Dermatol, Pierre Benite, France
[6] Rochester Skin Lymphoma Med Grp, PLLC, Fairport, NY USA
[7] Washington Univ, Dept Med, Div Oncol, St Louis, MO USA
[8] CHU Rouen, Hop Charles Nicolle, Dept Dermatol, Rouen, France
[9] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy
[10] Univ Ziekenhuis Leuven, Dept Gen Med Oncol, Leuven, Belgium
[11] Charite Univ Med Berlin, Dept Dermatol Venerol & Allergol, Berlin, Germany
[12] Hosp Clin Barcelona, Dept Dermatol, Barcelona, Spain
[13] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[14] Univ Paris Cite, Dept Pathol, Hop St Louis, INSERM U976, Paris, France
[15] Univ Virginia, Dept Pathol, Sch Med, Charlottesville, VA USA
[16] Univ Paris Cite, Hop St Louis, AP HP, Hematol Lab,INSERM 1160, Paris, France
[17] Innate Pharma, Marseille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7082
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Lacutamab in patients with relapsed and/or refractory mycosis fungoides: results from the TELLOMAK phase 2 trial
    Porcu, P.
    Bagot, M.
    Ram-Wolff, C.
    Huen, A. O.
    Dalle, S.
    Poligone, B.
    Mehta-Shah, N.
    Duval-Modeste, A. -B.
    Zinzani, P. L.
    Woei-A-Jin, S.
    Eigentler, T.
    Combalia, A.
    Sokol, L.
    Battistella, M.
    Gru, A.
    Moins-Teisserenc, H.
    Viotti, J.
    Paiva, C.
    Boyer-Chammard, A.
    Kim, Y. -H.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S26 - S27
  • [2] Lacutamab in Patients with Relapsed and Refractory Sezary Syndrome: Results from the Tellomak Phase 2 Trial
    Bagot, Martine
    Kim, Youn H.
    Geskin, Larisa J.
    Ortiz-Romero, Pablo L.
    Kim, Ellen
    Mehta-Shah, Neha
    Dereure, Olivier
    Oro, Saskia
    Beylot-Barry, Marie
    Dalle, Stephane
    Jacobsen, Eric
    Lansigan, Frederick
    Ram-Wolff, Caroline
    Khodadoust, Michael S.
    Battistella, Maxime
    Gru, Alejandro A.
    Moins-Teisserenc, Helene
    Zinzani, Pier Luigi
    Viotti, Julien
    Paiva, Christine
    Muller, Marianna
    Porcu, Pierluigi
    BLOOD, 2023, 142
  • [3] Lacutamab in Patients with Relapsed and Refractory Se′zary Syndrome: Results from the TELLOMAK Phase 2 Trial
    Bagot, M.
    Kim, Y. -H.
    Geskin, L. J.
    Ortiz-Romero, P. L.
    Kim, E.
    Mehta-Shah, N.
    Dereure, O.
    Oro, S.
    Beylot-Barry, M.
    Dalle, S.
    Jacobsen, E.
    Lansigan, F.
    Ram-Wolff, C.
    Khodadoust, M.
    Battistella, M.
    Gru, A.
    Moins-Teisserenc, H.
    Zinzani, P. L.
    Viotti, J.
    Paiva, C.
    Boyer-Chammard, A.
    Porcu, P.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S26 - S26
  • [4] Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial
    Bagot, M.
    Muller, M.
    Kim, Y. H.
    Ortiz-Romero, P. L.
    Zinzani, P. L.
    Beylot-Barry, M.
    Dalle, S.
    Jacobsen, E.
    Combalia, A.
    Huen, A.
    Mehta-Shah, N.
    Khodadoust, M. S.
    Viotti, J.
    Paiva, C.
    Porcu, P.
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : S20 - S21
  • [5] Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial
    Bagot, Martine
    Kim, Youn
    Zinzani, Pier Luigi
    Dalle, Stephane
    Beylot-Barry, Marie
    Ortiz-Romero, Pablo L.
    Cambalia, Andrea
    Dereure, Olivier
    Mortier, Laurent
    Jacobsen, Eric
    Battistella, Maxime
    Gru, Alejandro
    Moins-Teisserenc, Helene
    Paiva, Christine
    Boyer-Chammard, Agnes
    Rotolo, Federico
    Azim, Hatem A.
    Porcu, Pierluigi
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S20 - S21
  • [6] Lacutamab in patients with mycosis fungoides: efficacy results according to updated lymph node classification in the TELLOMAK study
    Bagot, Martine
    Kim, Youn H.
    Ortiz-Romero, Pablo L.
    Zinzani, Pier Luigi
    Beylot-Barry, Marie
    Dalle, Stephane
    Jacobsen, Eric
    Combalia, Andrea
    Huen, Auris
    Mehta-Shah, Neha
    Khodadoust, Michael
    Mehta, Amitkumar
    Dereure, Olivier
    Battistella, Maxime
    Gru, Alejandro
    Moins-Teisserenc, Helene
    Viotti, Julien
    Paiva, Christine
    Boyer-Chammard, Agnes
    Porcu, Pierluigi
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S19 - S20
  • [7] Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial
    Bagot, Martine
    Kim, Youn H.
    Ortiz-Romero, Pablo L.
    Zinzani, Pier Luigi
    Mehta-Shah, Neha
    Dereure, Olivier
    Beylot-Barry, Marie
    Dalle, Stephane
    Jacobsen, Eric D.
    Huen, Auris
    Combalia, Andrea
    Battistella, Maxime
    Gru, Alejandro A.
    Moins-Teisserenc, Helene
    Khodadoust, Michael S.
    Viotti, Julien
    Paiva, Christine
    Muller, Marianna
    Porcu, Pierluigi
    BLOOD, 2022, 140 : 3760 - 3761
  • [8] Durable Responses with Pembrolizumab in Relapsed/Refractory Mycosis Fungoides and Sezary Syndrome: Final Results from a Phase 2 Multicenter Study
    Khodadoust, Michael S.
    Rook, Alain
    Porcu, Pierluigi
    Foss, Francine M.
    Moskowitz, Alison J.
    Shustov, Andrei R.
    Shanbhag, Satish
    Sokol, Lubomir
    Fling, Steven P.
    Li, Shufeng
    Davis, Asa
    Fong, Sophia
    Kim, Jinah
    Yang, Yi
    Yearley, Jennifer H.
    Subrahmanyam, Priyanka B.
    Maecker, Holden T.
    Budovskaya, Yelena
    Das, Biswajit
    Patidar, Rajesh
    Datta, Vivekananda
    Karlovich, Chris
    Horwitz, Steven M.
    Sharon, Elad
    Kohrt, Holbrook
    Cheever, Martin A.
    Kim, Youn H.
    BLOOD, 2018, 132
  • [9] Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides
    Rupoli, Serena
    Canafoglia, Lucia
    Goteri, Gaia
    Leoni, Pietro
    Brandozzi, Giuliano
    Federici, Irene
    Micucci, Giorgia
    Giantomassi, Federica
    Mozzicafreddo, Giorgio
    Alterini, Renato
    Filosa, Giorgio
    Ricotti, Giuseppe
    Simonacci, Marco
    Scortechini, Anna Rita
    Zizzi, Antonio
    Pimpinelli, Nicola
    EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (01) : 13 - 20
  • [10] Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides
    Serena Rupoli
    Lucia Canafoglia
    Gaia Goteri
    Pietro Leoni
    Giuliano Brandozzi
    Irene Federici
    Giorgia Micucci
    Federica Giantomassi
    Giorgio Mozzicafreddo
    Renato Alterini
    Giorgio Filosa
    Giuseppe Ricotti
    Marco Simonacci
    Anna Rita Scortechini
    Antonio Zizzi
    Nicola Pimpinelli
    European Journal of Dermatology, 2016, 26 : 13 - 20
12345